Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
90 pending office actions • 37 art units • 73 examiners • 0 of 90 (0%) have an AI response strategy ready • 44 patents granted in the last 365 days
DSM IP Assets B.V. has 93 pending office actions in Biotechnology & Pharmaceuticals. The portfolio spans 73 examiners and 37 art units, indicating substantial distribution across the technology area. The difference between the office-action volume and the examiner count also indicates that some examiner relationships contain multiple matters, while the broader portfolio requires coordination across many separate examination paths.
DAVIS, RUTH A is the busiest examiner, with 3 pending matters. That concentration identifies a useful focal point for examiner-specific tracking, but it does not represent the full portfolio's operating pattern. Counsel should pair centralized docket oversight with claim and prior-art analysis tailored to each art-unit assignment.
The breadth of examiner and art-unit coverage makes standardized reporting particularly valuable. A portfolio dashboard can separate recurring technical issues from isolated objections, support consistent treatment of related claim concepts, and help allocate review resources without assuming that one examiner's approach applies across the entire portfolio.
Based on the USPTO statutory response window for each pending office action. 32 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 32 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 11 (12%) |
| §103 only | 34 (38%) |
| §102 only | 2 (2%) |
| §112 only | 2 (2%) |
| Double-patenting only | 1 (1%) |
| Double-patenting + other | 17 (19%) |
| Multi-statute (no §101) | 23 (26%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DAVIS, RUTH A | 3 | 60.9% | +31.0% |
| HAWKINS, AMANDA SALATA | 3 | 15.4% | +40.9% |
| CHANG, KYUNG SOOK | 2 | 60.5% | +40.8% |
| UNDERDAHL, THANE E | 2 | 58.8% | +50.2% |
| BERRY, LAYLA D | 2 | 66.0% | +9.0% |
| JACOBSON, MICHELE LYNN | 2 | 28.1% | +33.9% |
| BEKKER, KELLY JO | 2 | 16.8% | +35.1% |
| LEBLANC, KATHERINE DEGUIRE | 2 | 34.6% | +36.0% |
| PRAKASH, SUBBALAKSHMI | 2 | 45.6% | +36.2% |
| BREWSTER, HAYDEN R | 2 | 62.8% | +46.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18253175 | NEW SYNTHESIS OF L-PHENYLALANINE AMIDE | SAWYER, JENNIFER C | 153d overdue |
| 18253178 | NEW SYNTHESIS OF L-PHENYLALANINE BUTYRAMIDE | SAWYER, JENNIFER C | 147d overdue |
| 18256310 | IMPROVE THE WATER RESISTANCE OF COSMETIC COMPOSITIONS COMPRISING BISOCTRIZOLE | HOLLOMAN, NANNETTE | 126d overdue |
| 15734727 | MODIFIED RAPESEED PROTEIN ISOLATE | TRAN, LIEN THUY | 45d overdue |
| 17779959 | APPARATUS AND METHOD FOR DYNAMIC VISUALIZING AND ANALYZING MICROBIOME IN ANIMALS | SCHULTZHAUS, JANNA NICOLE | 15d overdue |
| 18554900 | METHOD FOR MONITORING THE USE OF A METHANE INHIBITOR | LE, JOHN H | 4d overdue |
| 19289461 | SUNSCREEN COMPOSITION BASED ON BEMT AND TWO OR MORE PIGMENTARY UV-FILTERS | ALAWADI, SARAH | 9d |
| 18710029 | HIGH POTENCY GRANULES OBTAINABLE BY CONTINUOUS MELT GRANULATION | BEKKER, KELLY JO | 12d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18546604 | COATED MEAT OR FISH SUBSTITUTE | PRAKASH, SUBBALAKSHMI | 112d overdue |
| 18710029 | HIGH POTENCY GRANULES OBTAINABLE BY CONTINUOUS MELT GRANULATION | BEKKER, KELLY JO | 12d |
| 18291819 | PROCESS FOR PRODUCTION OF A FERMENTED MILK PRODUCT USING GLUCOSE-FRUCTOSE OXIDOREDUCTASE | PRAKASH, SUBBALAKSHMI | 12d |
| 17906118 | USE OF PHYTASE TO OBTAIN IMPROVED FOOD | HAWKINS, AMANDA SALATA | 26d |
| 17842842 | PROCESS FOR PRODUCING OLIVE OIL | HAWKINS, AMANDA SALATA | 34d |
| 18691213 | PLANT BASED READY TO MIX COMPOSITION | LEBLANC, KATHERINE DEGUIRE | 46d |
| 18016544 | NEW FAST DISSOLVABLE TABLETS | HAWKINS, AMANDA SALATA | 83d |
| 18873973 | SUNSCREEN COMPOSITION FOR LACTOBACILLUS AND S. EPIDERMIDIS PROTECTION ON SKIN | CHANG, KYUNG SOOK | — |
| Art Unit | Apps |
|---|---|
| 1793 | 12 |
| 1791 | 7 |
| 1613 | 5 |
| 1699 | 5 |
| 1657 | 4 |
| 1693 | 4 |
| 1612 | 4 |
| 1792 | 4 |
| 1619 | 3 |
| 1616 | 3 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19289461 | SUNSCREEN COMPOSITION BASED ON BEMT AND TWO OR MORE PIGMENTARY UV-FILTERS | ALAWADI, SARAH | 1619 | §103§112 | Final Rejection | 9d | Pending | Aug 04, 2025 |
| 19115488 | ß-CAROTENE SYNTHESIS (II) | HINES, LATOSHA D | 1772 | §102 | Non-Final OA | — | Pending | Mar 26, 2025 |
| 19101147 | SUNSCREEN COMPOSITION | RUNYAN, SILVANA C | 1616 | §103§112 | Non-Final OA | — | Pending | Feb 04, 2025 |
| 18874257 | SEPARATION OF HUMAN MILK OLIGOSACCHARIDES FROM A FERMENTATION BROTH | SAIDHA, TEKCHAND | 1652 | §102§112DP | Non-Final OA | — | Pending | Dec 12, 2024 |
| 18873973 | SUNSCREEN COMPOSITION FOR LACTOBACILLUS AND S. EPIDERMIDIS PROTECTION ON SKIN | CHANG, KYUNG SOOK | 1613 | §101§112DP | Non-Final OA | — | Pending | Dec 11, 2024 |
| 18874006 | SUNSCREEN COMPOSITION FOR LACTOBACILLUS AND S. EPIDERMIDIS PROTECTION ON SKIN | CHANG, KYUNG SOOK | 1613 | §102§103§112DP | Non-Final OA | — | Pending | Dec 11, 2024 |
| 18873493 | USE OF UV FILTERS FOR THE TREATMENT OF ACNE | BREDEFELD, RACHAEL EVA | 3786 | §101§102§103§112 | Non-Final OA | — | Pending | Dec 10, 2024 |
| 18973575 | NEW SIALYLTRANSFERASES FOR IN VIVO SYNTHESIS OF 3'SL | SINGH, SATYENDRA K | 1657 | DP | Non-Final OA | — | Pending | Dec 09, 2024 |
| 18872675 | COMBINATIONS COMPRISING VITAMIN C AND LACTOBACILLUS RHAMNOSUS | DAVIS, RUTH A | 1699 | §102§103§112Other | Non-Final OA | — | Pending | Dec 06, 2024 |
| 18872690 | COMBINATIONS COMPRISING VITAMIN B2 AND LACTOBACILLUS RHAMNOSUS | GOUGH, TIFFANY MAUREEN | 1651 | §101§102§112DP | Non-Final OA | — | Pending | Dec 06, 2024 |
| 18871908 | COMBINATIONS COMPRISING VITAMIN C AND BIFIDOBACTERIUM ANIMALIS SSP. LACTIS | UNDERDAHL, THANE E | 1699 | §102§103§112DP | Non-Final OA | — | Pending | Dec 05, 2024 |
| 18871675 | VITAMINS FOR USE IN IMPROVING GUT HEALTH | UNDERDAHL, THANE E | 1653 | §102§103§112DP | Non-Final OA | — | Pending | Dec 04, 2024 |
| 18954372 | EARLY LIFE NUTRITION | PARK, HAEJIN S | 1614 | §101§103§112DP | Non-Final OA | — | Pending | Nov 20, 2024 |
| 18853279 | IMPROVEMENT OF THE WATER RESISTANCE OF COSMETIC COMPOSITIONS COMPRISING UV FILTERS | NGUYEN, NGOC-ANH THI | 1615 | §101§103§112DP | Non-Final OA | — | Pending | Oct 01, 2024 |
| 18827625 | STORAGE STABLE MIXTURES | LEE, SIN J | 1613 | §102§112DP | Non-Final OA | — | Pending | Sep 06, 2024 |
| 18809575 | PROCESSES FOR OBTAINING MICROBIAL OIL FROM MICROBIAL CELLS | CONSTANTINE, CHARLES Z | 1657 | §102§103DP | Non-Final OA | — | Pending | Aug 20, 2024 |
| 18809132 | STEVIOL GLYCOSIDE TRANSPORT | LEE, JAE W | — | §102§112Other | Non-Final OA | — | Pending | Aug 19, 2024 |
| 18838938 | SINGLE CELL PROTEIN PRODUCTS | AFREMOVA, VERA | 1653 | §101§102§103§112 | Non-Final OA | — | Pending | Aug 15, 2024 |
| 18834722 | YARROWIA PRODUCTION PROCESS | DAVIS, RUTH A | 1699 | §102§103§112 | Non-Final OA | — | Pending | Jul 31, 2024 |
| 18832718 | NOVEL USE | BERRY, LAYLA D | 1693 | §101§102§103§112DP | Non-Final OA | — | Pending | Jul 24, 2024 |
| 18730645 | 25-HYDROXYVITAMIN D AS A FEED ADDITIVE FOR AQUATIC ANIMALS | PACKARD, BENJAMIN J | 1612 | §102§103 | Final Rejection | — | Pending | Jul 19, 2024 |
| 18729670 | A FEED COMPOSITION AND USE THEREOF | JACOBSON, MICHELE LYNN | 1793 | §103 | Non-Final OA | — | Pending | Jul 17, 2024 |
| 18753538 | COMPRESSED TABLETS | ALAM, AYAAN A | 1611 | §103 | Final Rejection | — | Pending | Jun 25, 2024 |
| 18723269 | SYNTHETIC BIOPOLYMERS AND THEIR USE IN COMPOSITIONS FOR TISSUE REPAIR | GOTFREDSON, GAREN | 1619 | §102§103§112Other | Non-Final OA | — | Pending | Jun 23, 2024 |
| 18722445 | A METHOD FOR REDUCING AMMONIA EMISSION OF ANIMALS | YAMASAKI, ROBERT J | 1657 | §102§103§112 | Non-Final OA | — | Pending | Jun 20, 2024 |
| 18719751 | NEW COATING SYSTEM (I) | SCHLIENTZ, NATHAN W | 1616 | §103§112 | Non-Final OA | — | Pending | Jun 13, 2024 |
| 18741628 | METHODS OF FORMING STORAGE STABLE MIXTURES | WORSHAM, JESSICA N | 1615 | §103§112DP | Non-Final OA | — | Pending | Jun 12, 2024 |
| 18713284 | COMPOSITIONS HAVING HIGH LEVELS OF DPA (n-3) AND METHODS FOR PRODUCING | GWARTNEY, ELIZABETH A | 1759 | §103§112 | Non-Final OA | — | Pending | May 24, 2024 |
| 18710029 | HIGH POTENCY GRANULES OBTAINABLE BY CONTINUOUS MELT GRANULATION | BEKKER, KELLY JO | 1792 | §103 | Final Rejection | 12d | Pending | May 14, 2024 |
| 18709316 | GRANULE COMPRISING ENCAPSULATED ACTIVE INGREDIENTS | CRAIGO, WILLIAM A | 1615 | §103§112DP | Non-Final OA | — | Pending | May 10, 2024 |
| 18709330 | GRANULES OBTAINABLE BY CONTINUOUS MELT GRANULATION | VIGIL, TORIANA NICHOLE | 1612 | §102§103§112DP | Non-Final OA | — | Pending | May 10, 2024 |
| 18691184 | HIGH-MOISTURE TEXTURIZED VEGETABLE PROTEIN | LIU, DEBORAH YANG-HAO | 1791 | §103 | Final Rejection | 8d overdue | Pending | Mar 12, 2024 |
| 18691213 | PLANT BASED READY TO MIX COMPOSITION | LEBLANC, KATHERINE DEGUIRE | 1791 | §103 | Final Rejection | 46d | Pending | Mar 12, 2024 |
| 18685028 | NOVEL USE OF AT LEAST A HUMAN MILK OLIGOSACCHARIDE | CRAIGO, BAHAR ALAWI | 1699 | §102§103 | Non-Final OA | — | Pending | Feb 20, 2024 |
| 18684736 | EXTRUSION APPARATUS | MALEKZADEH, SEYED MASOUD | 1754 | §103 | Non-Final OA | — | Pending | Feb 19, 2024 |
| 18291626 | A METHOD AND SYSTEM FOR DETERMINING A QUANTITATIVE COMPOSITION RATIO OF A MICROBIAL STRAIN MIXTURE FOR USE IN A FERMENTATION PROCESS | CRUM, MARY ABOU NADER | 1657 | §102§103 | Final Rejection | — | Pending | Jan 24, 2024 |
| 18291819 | PROCESS FOR PRODUCTION OF A FERMENTED MILK PRODUCT USING GLUCOSE-FRUCTOSE OXIDOREDUCTASE | PRAKASH, SUBBALAKSHMI | 1793 | §103 | Final Rejection | 12d | Pending | Jan 24, 2024 |
| 18569986 | SEPARATION OF HUMAN MILK OLIGOSACCHARIDES FROM A FERMENTATION BROTH | BREWSTER, HAYDEN R | 1779 | §102§112DP | Non-Final OA | — | Pending | Dec 13, 2023 |
| 18570003 | SEPARATION OF HUMAN MILK OLIGOSACCHARIDES FROM A FERMENTATION BROTH | BREWSTER, HAYDEN R | 1779 | §102§103§112DP | Non-Final OA | — | Pending | Dec 13, 2023 |
| 18570021 | SEPARATION OF HUMAN MILK OLIGOSACCHARIDES FROM A FERMENTATION BROTH | LEWIS, PATRICK T | 1691 | §103 | Final Rejection | — | Pending | Dec 13, 2023 |
| 18563134 | FED-BATCH FERMENTATION PROCESS | HURST, JONATHAN M | 1799 | §102§103§112 | Non-Final OA | — | Pending | Nov 21, 2023 |
| 18561123 | METHODS OF PRODUCTING HMO BLEND PROFILES WITH LNFP-1 AND 2'-FL AS THE PREDOMINANT COMPOUNDS | ARMATO JR, DENNIS IGNATIUS | 1651 | §103 | Final Rejection | 44d overdue | Pending | Nov 15, 2023 |
| 18387765 | CLEAR LIQUID CAROTENOID FORMULATIONS AND CLEAR BEVERAGES CONTAINING THEM | MCCLAIN, TYNESHA L. | 1793 | §103§112 | Final Rejection | 21d | Pending | Nov 07, 2023 |
| 18559242 | PURIFICATION OF SPECIFIC TRIPEPTIDE BY USE OF ETHERS | KATAKAM, SUDHAKAR | 1658 | §103 | Non-Final OA | — | Pending | Nov 06, 2023 |
| 18559251 | PURIFICATION OF SPECIFIC TRIPEPTIDE BY ACIDIFICATION | BRADLEY, CHRISTINA | 1654 | §103 | Non-Final OA | — | Pending | Nov 06, 2023 |
| 18556213 | COUPLING OF 2,3,5-TRIMETHYLHYDROQUINONE AND UNSATURATED ALCOHOLS | FEELY, MICHAEL J | 1766 | §103§112 | Non-Final OA | — | Pending | Oct 19, 2023 |
| 18555329 | USE OF PROPANDIOL MONONITRATE AND LIMONENE FOR REDUCING THE FORMATION OF METHANE EMANATING AND FOR IMPROVING THE DIGESTIBILITY | MERRIAM, ANDREW E | 1791 | §103 | Final Rejection | 7d | Pending | Oct 13, 2023 |
| 18555070 | RETINOL FORMULATION (II) | LIU, SUE XU | 1616 | §103§112DP | Non-Final OA | — | Pending | Oct 12, 2023 |
| 18555154 | RETINOL FORMULATION (III) | JACKSON, SHAWQUIA | 1626 | §112DP | Non-Final OA | — | Pending | Oct 12, 2023 |
| 18555104 | RETINOL FORMULATION (I) | BARSKY, JARED | 1628 | §103 | Final Rejection | 12d | Pending | Oct 12, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialDSM IP Assets B.V. has 90 pending office actions as of October 2026, spread across 37 art units and 73 examiners.
Ruth A Davis has the most, with 3 of DSM IP Assets B.V.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
